Delving into the Latest Updates on COVID-19 (Healx) with Synapse

Overview

Basic Info

Drug Type

Chemical drugs

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication

COVID-19

Inactive Indication-

Originator Organization

Healx Ltd.

Active Organization

Healx Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePreclinical

First Approval Date-

Regulation-

This case report, shows two cases of COVID-19 vaccine- related cutaneous allergic adverse reaction as a mild form of drug eruption.Case 1 a 48-yr- old female developed an erythematous eruption on the trunk and extremities 3 days after the second administration of BioNTech COVID-19 vaccine (Pfizer) without p.o. administration of acetaminophen or non- steroidal anti- inflammatory drugs (NSAIDs).Her skin eruption was rapidly improved by topical betamethasone propionate within 7 days of the treatment.Case 2 a 58- year-old female noticed itchy erythematous papules 4 days after the second BioNTech COVID- 19 vaccination (Pfizer) without p.o. administration of acetaminophen or NSAIDs.Her skin eruption was improved within 7 days of p.o. administration of an antihistamine drug and topical hydrocortisone butyrate.Although this case showed a mild form of drug eruption, further observational study is necessary to clarify the detailed characteristics of drug eruption by COVID- 19 vaccine.

01 May 2021·Schizophrenia Research

COVID 19 vaccination of persons with schizophrenia in India – Need for imperative action!

Letter

Author: Suhas, Satish

100 Deals associated with COVID-19 (Healx)

Login to view more data